Guo Jiguang, Tao Wu, Tang Dan, Zhang Jianbin
Department of Nephrology, YongChuan Hospital of ChongQing Medical University, ChongQing - China.
Department of Intensive Care Unit, YongChuan Hospital of ChongQing Medical University, ChongQing - China.
Int J Artif Organs. 2017 Oct 27;40(11):607-614. doi: 10.5301/ijao.5000625. Epub 2017 Jul 14.
We assessed the Th17 (T-helper cell)/Treg (Regulatory T cell) imbalance in sepsis patients with multiple organ dysfunction syndrome (MODS) and the clinical benefits of continuous high-volume hemofiltration (HVHF).
48 sepsis patients, including 22 patients with MODS (MODS group, n = 22) and 26 without (non-MODS group, n = 26), and 20 healthy volunteer controls were enrolled. The patients in MODS group were randomly divided into the continuous blood purification (CBP) group (n = 11) receiving conventional comprehensive treatment plus high-volume hemofiltration and the non-CBP group (n = 11) receiving conventional comprehensive treatment only. At day 28, all 48 patients were divided into the survival group (n = 36) and the non-survival group (n = 12). Venous blood samples, collected at 0, 6, 12 and 24 hours during hemofiltration (or equivalent times in the non-CBP group), were assessed by flow cytometry to detect the Th17 and Treg cells in peripheral blood. Serum cytokines (such as IL-6, IL-17, IL-23, IL-10 and TGF-β1) were detected by enzyme-linked immune sorbent assay (ELISA).
Th17%, Treg%, Th17/Treg, IL-6, IL-17, IL-23, IL-10 and TGF-β1 were significantly higher in MODS and non-MODS group than in the health control (p<0.05), while Th17%, Treg%, Th17/Treg and measured cytokines were significantly higher in the MODS group compared to the non-MODS group (p<0.05). After HVHF treatment, Th17%, Treg%, Th17/Treg, IL-6, IL-17, and IL-10 were significantly reduced (p<0.05), while there were no significant changes in the non-CBP group (p>0.05). In addition, APACHE II and SOFA scores decreased markedly after HVHF treatment. Baseline Th17%, Treg%, Th17/Treg, IL-6, IL-17, IL-23, IL-10 and TGF-β1 were significantly higher in the non-survival group compared to the survival group. Both Th17% and Th17/Treg were positivity correlated with concentration of IL-6 and APACHE II score (p<0.01).
The level of Th17/Treg imbalance in sepsis is related to the occurrence and prognosis of MODS. High-volume hemofiltration can attenuate the Th17/Treg imbalance in sepsis patients, possibly by removing inflammatory mediators.
我们评估了多器官功能障碍综合征(MODS)脓毒症患者的Th17(辅助性T细胞)/Treg(调节性T细胞)失衡情况以及持续高容量血液滤过(HVHF)的临床益处。
纳入48例脓毒症患者,其中包括22例患有MODS的患者(MODS组,n = 22)和26例未患MODS的患者(非MODS组,n = 26),以及20名健康志愿者作为对照。MODS组患者被随机分为接受常规综合治疗加高容量血液滤过的持续血液净化(CBP)组(n = 11)和仅接受常规综合治疗的非CBP组(n = 11)。在第28天,将所有48例患者分为存活组(n = 36)和非存活组(n = 12)。在血液滤过期间的0、6、12和24小时(或非CBP组的等效时间)采集静脉血样本,通过流式细胞术评估外周血中的Th17和Treg细胞。采用酶联免疫吸附测定(ELISA)检测血清细胞因子(如IL-6、IL-17、IL-23、IL-10和TGF-β1)。
MODS组和非MODS组的Th17%、Treg%、Th17/Treg、IL-6、IL-17、IL-23、IL-10和TGF-β1均显著高于健康对照组(p<0.05),而MODS组的Th17%、Treg%、Th17/Treg及检测的细胞因子显著高于非MODS组(p<0.05)。HVHF治疗后,Th17%、Treg%、Th17/Treg、IL-6、IL-17和IL-10显著降低(p<0.05),而非CBP组无显著变化(p>0.05)。此外,HVHF治疗后APACHE II和SOFA评分显著降低。非存活组的基线Th17%、Treg%、Th17/Treg、IL-6、IL-17、IL-23、IL-10和TGF-β1显著高于存活组。Th17%和Th17/Treg均与IL-6浓度和APACHE II评分呈正相关(p<0.01)。
脓毒症中Th17/Treg失衡水平与MODS的发生和预后相关。高容量血液滤过可减轻脓毒症患者的Th17/Treg失衡,可能是通过清除炎症介质实现的。